优化治疗高风险的生化复发性非转移性前列腺癌:当前和新兴的策略
Christian Kollmannsberger1, Antonio Finelli2, Andrew Loblaw3
1Department of Medical Oncology, BC Cancer Vancouver Center, Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada.
概括
生物化学复发 (BCR) 影响近三分之一的前列腺癌患者,增加转移和死亡风险. 本综述指导临床医生使用先进的成像和不断发展的疗法来管理BCR.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 前列腺癌是全球重要的健康问题,特别是在加拿大.
- 生化复发 (BCR),以治疗后前列腺特异性抗原 (PSA) 水平上升为标志,影响约30%的患者.
- BCR与更高的癌症转移和死亡风险有关,需要有效的管理策略.
研究的目的:
- 为临床医生提供实际指导,帮助他们管理患有BCR的前列腺癌患者.
- 审查高级成像在BCR检测和管理中的实用性和解释.
- 探索BCR的当代治疗模式,包括救援疗法和新药组合.
主要方法:
- 这是一篇综述性文章,综合了当前的文献和临床指南.
- 它侧重于在BCR中解释先进的成像模式 (例如PSMA PET扫描).
- 该审查审查了救援治疗的证据,并将雄激素剥夺疗法 (ADT) 与雄激素受体通路抑制剂 (ARPI) 的整合.
主要成果:
- 先进的成像在确定复发性前列腺癌的程度和位置方面发挥着至关重要的作用.
- 对BCR的管理决策越来越多地基于成像发现和患者特定因素来个性化.
- 新兴的治疗策略,包括ADT与ARPI结合,在改善BCR患者的治疗结果方面表现有前途.
结论:
- 前列腺癌BCR的有效管理需要将先进的成像与不断发展的治疗选择相结合.
- 临床医生需要更新的指导,以应对BCR诊断和治疗的复杂性.
- 个性化治疗方法是改善复发性前列腺癌患者的生存率和生活质量的关键.
更多相关视频
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
16.5K
07:34Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
Published on: November 17, 2023
584
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K